XML 23 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024   4,563 30,499,931        
Beginning balance at Dec. 31, 2024 $ (456,016) $ 0 $ 3 $ 589,387 $ (1,070,996) $ (6,569) $ 32,159
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued, in connection with employment agreement (in shares)     100,000        
Common stock issued, in connection with employment agreement 295     295      
RSU equity awards reclassified from liability 0            
RSU equity awards reclassified to liability (2,138)     (2,138)      
Common stock forfeited (in shares)     (2,865)        
Warrants issued 1,600     1,600      
Share-based payments 6,336     6,336      
Share-based payments in equity of subsidiary 1,593     23     1,570
Vesting of shares in equity of subsidiary (71)     (71)      
Dividend forfeitures on unvested equity awards 257       257    
Net income (loss) 124,432       129,496   (5,064)
Distributions to noncontrolling interests (3,249)           (3,249)
Common stock issuance in equity of subsidiary 1,575           1,575
Disposition from sale and deconsolidation of businesses 2,918           2,918
Initial consolidation of VIE 12,494           12,494
Other comprehensive income (loss) 671         671  
Ending balance (in shares) at Jun. 30, 2025   4,563 30,597,066        
Ending balance at Jun. 30, 2025 (309,303) $ 0 $ 3 595,432 (941,243) (5,898) 42,403
Beginning balance (in shares) at Mar. 31, 2025   4,563 30,497,066        
Beginning balance at Mar. 31, 2025 (453,970) $ 0 $ 3 591,207 (1,080,971) (7,056) 42,847
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued, in connection with employment agreement (in shares)     100,000        
Common stock issued, in connection with employment agreement 295     295      
Warrants issued 737     737      
Share-based payments 3,193     3,193      
Share-based payments in equity of subsidiary 1,277           1,277
Dividend forfeitures on unvested equity awards 257       257    
Net income (loss) 140,999       139,471   1,528
Distributions to noncontrolling interests (3,249)           (3,249)
Other comprehensive income (loss) 1,158         1,158  
Ending balance (in shares) at Jun. 30, 2025   4,563 30,597,066        
Ending balance at Jun. 30, 2025 (309,303) $ 0 $ 3 595,432 (941,243) (5,898) 42,403
Beginning balance (in shares) at Dec. 31, 2025   4,563 30,597,066        
Beginning balance at Dec. 31, 2025 (120,262) $ 0 $ 3 598,022 (763,286) (6,272) 51,271
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued, in connection with redemption of Senior Notes (in shares)     8,358,495        
Common stock issued, in connection with redemption of Senior Notes 67,785   $ 1 67,784      
Common stock issued, in connection with the exercise of warrants (in shares)     915,251        
Common stock issued, in connection with the exercise of warrants 9,400     9,400      
RSU equity awards reclassified from liability 2,589     2,589      
Vesting of restricted stock, net of shares withheld for employer taxes (in shares)     328,943        
Vesting of restricted stock, net of shares withheld for employer taxes (929)     (929)      
RSU equity awards reclassified to liability 0            
Share-based payments 3,231     3,231      
Share-based payments in equity of subsidiary 1,121           1,121
Vesting of shares in equity of subsidiary (1,902)           (1,902)
Net income (loss) 243,756       233,822   9,934
Distributions to noncontrolling interests (1,358)           (1,358)
Common stock issuance in equity of subsidiary 0            
Other comprehensive income (loss) (2,196)         (2,196)  
Ending balance (in shares) at Jun. 30, 2026   4,563 40,199,755        
Ending balance at Jun. 30, 2026 201,235 $ 0 $ 4 680,097 (529,464) (8,468) 59,066
Beginning balance (in shares) at Mar. 31, 2026   4,563 35,150,932        
Beginning balance at Mar. 31, 2026 136,332 $ 0 $ 4 634,479 (550,013) (7,149) 59,011
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock issued, in connection with redemption of Senior Notes (in shares)     3,804,629        
Common stock issued, in connection with redemption of Senior Notes 34,284     34,284      
Common stock issued, in connection with the exercise of warrants (in shares)     915,251        
Common stock issued, in connection with the exercise of warrants 9,400     9,400      
Vesting of restricted stock, net of shares withheld for employer taxes (in shares)     328,943        
Vesting of restricted stock, net of shares withheld for employer taxes (929)     (929)      
Share-based payments 2,863     2,863      
Share-based payments in equity of subsidiary 365           365
Net income (loss) 21,597       20,549   1,048
Distributions to noncontrolling interests (1,358)           (1,358)
Other comprehensive income (loss) (1,319)         (1,319)  
Ending balance (in shares) at Jun. 30, 2026   4,563 40,199,755        
Ending balance at Jun. 30, 2026 $ 201,235 $ 0 $ 4 $ 680,097 $ (529,464) $ (8,468) $ 59,066